SCHEMBL13735652

SCHEMBL13735652

CC1CN(c2ccncc2[N+](=O)[O-])CC(NC(=O)O)C1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KMT2A Q03164 2/20 0.31
HTT P42858 2/20 0.31
POLB P06746 1/20 0.31
MEN1 O00255 1/20 0.30
PIM2 Q9P1W9 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3225661 1.00 MAPT (0.35) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL3225648 1.00 MAPT (0.35) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL3225672 1.00 MAPT (0.35) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL18430028 0.91 MAPT (0.34) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL13421932 0.91 MAPT (0.34) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL16505472 0.90 MAPT (0.33) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL16505471 0.90 MAPT (0.33) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL16505469 0.90 MAPT (0.33) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL17420347 0.90 MAPT (0.33) MAPTALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL17420350 0.90 MAPT (0.33) MAPTALDH1A1LMNAMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2702063-A1 BICYCLIC PYRIDAZINE COMPOUNDS AS PIM INHIBITORS Amgen Inc. (US) 2014-03-05 EP disclosed
WO-2012148775-A1 BICYCLIC PYRIDAZINE COMPOUNDS AS PIM INHIBITORS AMGEN INC. (US) 2012-11-01 WO disclosed